SIGA Technologies announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer, CEO, effective January 27, 2024, and will also be appointed to the Company’s Board of Directors. SIGA‘s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024. As CEO, Dr. Nguyen will lead SIGA’s ongoing efforts in the development, manufacture and global distribution of antiviral therapies for the treatment of infectious diseases including smallpox, mpox, and other diseases associated with orthopox viruses. Dr. Nguyen joins SIGA from Xalud Therapeutics, a clinical stage biotechnology company developing treatments for inflammatory diseases, including pain associated with osteoarthritis, and neurodegenerative diseases, where she served as CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SIGA:
